Fusion-Guided Biopsies in Active Surveillance for Patients With Prostate Cancer

EP: 1.The Role of Imaging in Diagnosing and Staging Prostate Cancer

EP: 2.Advances in Prostate Biopsy

EP: 3.Benefits of Incorporating Fusion-Guided Biopsy into Practice

EP: 4.A Review of the Data for Fusion-Based Biopsy Procedures

EP: 5.Understanding Differences in Fusion-Guided Biopsy Technologies

EP: 6.The Role for Systematic Biopsy Plus MRI-Targeted Procedures

Now Viewing

EP: 7.Fusion-Guided Biopsies in Active Surveillance for Patients With Prostate Cancer

EP: 8.Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy

EP: 9.Incorporating Fusion-Guided Biopsy to Practice

EP: 10.Future Directions for Imaging and Biopsy in Prostate Cancer

EP: 11.The Impact of MRI-Guided Biopsy in Diagnosis and Treatment Decisions

EP: 12.Overcoming Limitations of Traditional Biopsies with MRI-Guided Biopsies

EP: 13.An Overview of Fusion-Guided Systems

EP: 14.Fusion-Based Biopsies in Active Surveillance

EP: 15.Expert Insights on MRI-US Fusion-Guided Biopsy

EP: 16.The Impact of Fusion-Guided Biopsy on Focal Therapy in Prostate Cancer

EP: 17.Looking Ahead: Image-Guided Diagnostic Tools

Video content above is prompted by the following questions:

• Is there a role for fusion-guided biopsies in active surveillance for patients with prostate cancer?
• Historically what has been the standard approach for active surveillance? Which patients? How often do you monitor?
• How can fusion-guided biopsies improve surveillance strategies and inform treatment and management decisions to improve outcomes?